References
- Borm PJ, Schins RP. Genotype and phenotype in susceptibility to coal workers' pneumoconiosis. The use of cytokines in perspective. Eur Respir J Suppl. 2001;32:127s-133s.
- Castranova V, Vallyathan V. Silicosis and coal workers' pneumoconiosis. Environ Health Perspect. 2000;108 (suppl 4):675-684.
- Katsnelson BA, Polzik EV, Privalova LI. Some aspects of the problem of individual predisposition to silicosis. Environ Health Perspect. 1986;68:175-185.
- Yucesoy B, Vallyathan V, Landsittel DP, et al. Cytokine polymorphisms in silicosis and other pneumoconioses. Mol Cell Biochem. 2002;234-235:219-224.
- Corbett EL, Mozzato-Chamay N, Butterworth AE, et al. Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners. Am J Respir Crit Care Med. 2002;165:690-693.
- Kim KA, Cho YY, Cho JS, et al. Tumor necrosis factor-alpha gene promoter polymorphism in coal workers' pneumoconiosis. Mol Cell Biochem. 2002;234-235:205-209.
- Schins RP, Borm PJ. Mechanisms and mediators in coal dust induced toxicity: a review. Ann Occup Hyg. 1999;43:7-33.
- Porcher JM, Lafuma C, el Nabout R, et al. Biological markers as indicators of exposure and pneumoconiotic risk: prospective study. Int Arch Occup Environ Health. 1993;65:S209-S213.
- Vallyathan V, Goins M, Lapp LN, et al. Changes in bronchoalveolar lavage indices associated with radiographic classification in coal miners. Am J Respir Crit Care Med. 2000;162:958-965.
- Magnusson MK, Mosher DF. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol. 1998;18:1363-1370.
- Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med. 2000;342:1792-1801.
- Berton A, Lorimier S, Emonard H, et al. Contribution of the plasmin/matrix metalloproteinase cascade to the retraction of human fibroblast populated collagen lattices. Mol Cell Biol Res Commun. 2000;3:173-180.
- De Petro G, Copeta A, Barlati S. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res. 1994;213:286-294.
- De Petro G, Tavian D, Marchina E, et al. Induction of fibronectin mRNA by urokinase- and tissue-type plasminogen activator in human skin fibroblasts: differential role of u-PA and t-PA at the fibronectin protein level. Biol Chem. 2002;383:177-187.
- Kucharewicz I, Kowal K, Buczko W, et al. The plasmin system in airway remodeling. Thromb Res. 2003;112:1-7.
- Przybylowska K, Smolarczyk K, Kulig A, et al. Antigen levels of the urokinase-type plasminogen activator and its gene polymorphisms in colorectal cancer. Cancer Lett. 2002;181:23-30.
- Jern C, Ladenvall P, Wall U, et al. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA. Arterioscler Thromb Vasc Biol. 1999;19:454-459.
- Dawson SJ, Wiman B, Hamsten A, et al. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993;268:10739-10745.
- Yang SC, Yang SP. Ventilatory function of progressive massive fibrosis among bituminous coal miners in Taiwan. Arch Environ Health. 2003;58:290-297.
- American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107-1136.
- Office IL. Guidelines for the Use of ILO International Classification of Radiographs of Pneumoconiosis. Series 22: ILO. Geneva, Switzerland: Occupational Safety and Health; 1981.
- Shen HN, Jerng JS, Yu CJ, et al. Outcome of coal worker's pneumoconiosis with acute respiratory failure. Chest. 2004;125:1052-1058.
- Ridker PM, Baker MT, Hennekens CH, et al. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol. 1997;17:1687-1690.
- Wong TY, Poon P, Szeto CC, et al. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int. 2000;57:632-638.
- Kleinbaum D, Klein M. Logistic Regression: A Self-Learning Text. 2nd ed. New York: Springer Science+Business Media; 2002.
- Cheung KH, Osier MV, Kidd JR, et al. ALFRED: an allele frequency database for diverse populations and DNA polymorphisms. Nucleic Acids Res. 2000;28:361-363.
- Jeng JR. Association of PAI-1 gene promoter 4g/5g polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension. Am J Hypertens. 2003;16:290-296.
- Zhai R, Jetten M, Schins RP, et al. Polymorphisms in the promoter of the tumor necrosis factor-alpha gene in coal miners. Am J Ind Med. 1998;34:318-324.
- Wang XT, Ohtsuka Y, Kimura K, et al. Antithetical effect of tumor necrosis factor-alpha gene polymorphism on coal workers' pneumoconiosis (CWP). Am I J Ind Med. 2005;48:24-29.
- Nadif R, Mintz M, Rivas-Fuentes S, et al. Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis. Cytokine. 2006;33:171-178.
- Zhai R, Liu G, Ge X, et al. Genetic polymorphisms of MnSOD, GSTM1, GSTT1, and OGG1 in coal workers' pneumoconiosis. J Occup Environ Med. 2002;44:372-377.
- Yucesoy B, Johnson VJ, Kashon ML, et al. Lack of association between antioxidant gene polymorphisms and progressive massive fibrosis in coal miners. Thorax. 2005;60:492-495.
- Yoshimoto M, Ushiyama Y, Sakai M, et al. Characterization of single chain urokinase-type plasminogen activator with a novel amino-acid substitution in the kringle structure. Biochim Biophys Acta. 1996;1293:83-89.
- Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med. 2003;31:S213-S220.
- Cho SH, Hall IP, Wheatley A, et al. Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma. J Allergy Clin Immunol. 2001;108:212-214.
- Hizawa N, Maeda Y, Konno S, et al. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility. Clin Exp Allergy. 2006;36:872-876.
- Kim KK, Flaherty KR, Long Q, et al. A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol Med. 2003;9:52-56.
- Cohen R, Velho V. Update on respiratory disease from coal mine and silica dust. Clin Chest Med. 2002;23:811-826.